Search Results

Efficacy and safety of neoadjuvant S-1-based chemoradiotherapy in resectable and borderline-resectable pancreatic cancer: a long-term follow-up study.

• Authors : Shimane G; Department of Surgery, Keio University School of Medicine, 35 Shinano-Machi Shinjuku-Ku, Tokyo, 160-8582, Japan.; Kitago M

Subjects: Tegafur*/Tegafur*/Tegafur*/administration & dosage ; Tegafur*/Tegafur*/Tegafur*/therapeutic use ; Oxonic Acid*/Oxonic Acid*/Oxonic Acid*/administration & dosage

• Source: World journal of surgical oncology [World J Surg Oncol] 2024 Dec 20; Vol. 22 (1), pp. 336. Date of Electronic Publication: 2024 Dec 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

Record details

Effectiveness of neoadjuvant chemotherapy with a docetaxel, cisplatin, and S-1 (DCS) regimen for T4b gastric cancer.

• Authors : Long VD; Department of Gastro-intestinal Surgery, University Medical Center, University of Medicine and Pharmacy at Ho Chi Minh City, 215 Hong Bang, Ward 11, District 5, Ho Chi Minh City, Vietnam. .; Department of General Surgery, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam. .

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/drug therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/surgery

• Source: World journal of surgical oncology [World J Surg Oncol] 2024 Dec 20; Vol. 22 (1), pp. 335. Date of Electronic Publication: 2024 Dec 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

Record details

Adjuvant tegafur-uracil (UFT) or S-1 monotherapy for advanced gastric cancer: a single center experience.

• Authors : Yen HH; Department of Surgery, National Taiwan University Biomedical Park Hospital, Hsinchu County, Taiwan.; Department of Surgery, National Taiwan University Hospital, No. 7 Chung-Shan South Rd, Zhongzheng District, Taipei, 10002, Taiwan.

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*therapeutic use ; Oxonic Acid/Oxonic Acid/Oxonic Acid/*therapeutic use ; Stomach Neoplasms/Stomach Neoplasms/Stomach Neoplasms/*drug therapy

• Source: World journal of surgical oncology [World J Surg Oncol] 2021 Apr 17; Vol. 19 (1), pp. 124. Date of Electronic Publication: 2021 Apr 17.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

Record details

Total gastrectomy increases the incidence of grade III and IV toxicities in patients with gastric cancer receiving adjuvant TS-1 treatment.

• Authors : Chou WC; Chang CL; Liu KH

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*adverse effects ; Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/*epidemiology ; Gastrectomy/Gastrectomy/Gastrectomy/*adverse effects

• Source: World journal of surgical oncology [World J Surg Oncol] 2013 Nov 01; Vol. 11, pp. 287. Date of Electronic Publication: 2013 Nov 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

Record details

A complete response to S-1 plus cis-diamminedichloroplatinum in advanced-stage esophageal and gastric adenocarcinoma: a case report.

• Authors : Matsuno Y; Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan. .; Kochi M

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*therapeutic use ; Cisplatin/Cisplatin/Cisplatin/*therapeutic use

• Source: World journal of surgical oncology [World J Surg Oncol] 2012 Jul 03; Vol. 10, pp. 133. Date of Electronic Publication: 2012 Jul 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

Record details

Erratum to: Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis

• Authors : Nakagawa, Ryosuke; Inoue, Yuji; Ohki, Takeshi

• Source: World Journal of Surgical Oncology. September 15, 2017, Vol. 15 Issue 1

Record details

Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis

• Authors : Nakagawa, Ryosuke; Inoue, Yuji; Ohki, Takeshi

• Source: World Journal of Surgical Oncology. May 31, 2017, Vol. 15 Issue 1

Record details

Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.

• Authors : Ryosuke Nakagawa; Yuji Inoue; Takeshi Ohki

Subjects: CHEMORADIOTHERAPY; RECTAL cancer patients; RECTAL cancer treatment

• Source: World Journal of Surgical Oncology; 5/31/2017, Vol. 15, p1-9, 9p

Record details

Efficacy and safety of maintenance therapy with anlotinib for advanced cholangiocarcinoma after first-line chemotherapy and the variations in efficacy based on different neutrophil-to-lymphocyte ratio (NLR).

• Authors : Li, Hui; Zhang, Jue; Gu, Lili

Subjects: ANLOTINIB; NEUTROPHIL lymphocyte ratio; BILIARY tract cancer

• Source: World Journal of Surgical Oncology; 7/29/2024, Vol. 22 Issue 1, p1-9, 9p

Record details

Erratum to: Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.

Subjects: CHEMORADIOTHERAPY; CANCER patients

• Source: World Journal of Surgical Oncology; 9/15/2017, Vol. 15, p1-1, 1p

Record details